{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:13:15Z","timestamp":1783501995295,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007436","name":"Erling-Persson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106348","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:10:52Z","timestamp":1782418252000},"page":"106348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-0939","authenticated-orcid":false,"given":"Amol Keshavasa","family":"Bhandage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Stascheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Pre\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-5342","authenticated-orcid":false,"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-9413","authenticated-orcid":false,"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106348_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106348_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in CIDP","volume":"91","author":"Koike","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106348_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106348_bib5","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14737175.2021.1944104","article-title":"Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice","volume":"21","author":"Allen","year":"2021","journal-title":"Expert Rev Neurother"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2026.106348_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8027.2011.00297.x","article-title":"Biomarkers in the diagnosis and therapy of CIDP: proceedings of the biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece","volume":"16","author":"Latov","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ebiom.2026.106348_bib8","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/cells12202456","article-title":"Current biomarker strategies in autoimmune neuromuscular diseases","volume":"12","author":"Oeztuerk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2026.106348_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1756285611405564","article-title":"Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"4","author":"Yoon","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ebiom.2026.106348_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","article-title":"Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice","volume":"15","author":"Gorson","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ebiom.2026.106348_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1474-4422(24)00309-0","article-title":"Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial","volume":"23","author":"Allen","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib12","series-title":"A phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic inflammatory demyelinating polyneuropathy","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106348_bib13","series-title":"A phase 3, randomized, double-blinded, double-dummy study evaluating the efficacy and safety of empasiprubart versus intravenous immunoglobulin in adults with multifocal motor neuropathy","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106348_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200419","article-title":"Serum neurofilament light chain as a biomarker for CIDP diagnosis, severity, and treatment outcome","volume":"12","author":"Klimas","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ebiom.2026.106348_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/ijms25021254","article-title":"Serum neurofilament and free light chain levels in patients undergoing treatment for chronic inflammatory demyelinating polyneuropathy","volume":"25","author":"Luigetti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106348_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.723009","article-title":"Calprotectin in chronic inflammatory demyelinating polyneuropathy and Variants-A potential novel biomarker of disease activity","volume":"12","author":"Stascheit","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200542","article-title":"Aberrant complement activation is a prominent feature of chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Stascheit","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ebiom.2026.106348_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2017.11.008","article-title":"Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy","volume":"476","author":"Chang","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2026.106348_bib19","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1093\/brain\/awad234","article-title":"Peripherin is a biomarker of axonal damage in peripheral nervous system disease","volume":"146","author":"Keddie","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2026.106348_bib20","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1093\/brain\/awaf234","article-title":"Plasma periaxin is a biomarker of peripheral nerve demyelination","volume":"148","author":"Bellanti","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2026.106348_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13578-023-00956-1","article-title":"Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Fu","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.ebiom.2026.106348_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jnnp-2023-332398","article-title":"Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy","volume":"95","author":"Wieske","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106348_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1241199","article-title":"Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay","volume":"14","author":"Kmezic","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106348_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70426","article-title":"AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 validated as Myasthenia Gravis biomarkers: a comparative proteomic Study with MS, CIDP, and controls","volume":"32","author":"Bhandage","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib25","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mus.27726","article-title":"Disease activity in chronic inflammatory demyelinating polyneuropathy: a comparative study of clinical and skin biopsy markers","volume":"66","author":"Acarli","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ebiom.2026.106348_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001031","article-title":"Interleukin 8, a biomarker to differentiate Guillain-Barre Syndrome from CIDP","volume":"8","author":"Breville","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ebiom.2026.106348_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jnnp-2020-324445","article-title":"CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS","volume":"92","author":"Capodivento","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106348_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106348_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365513.2018.1550810","article-title":"Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay","volume":"79","author":"\u00c5sberg","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ebiom.2026.106348_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ebiom.2026.106348_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106348_bib32","doi-asserted-by":"crossref","first-page":"20.10.1","DOI":"10.1002\/0471142727.mb2010s109","article-title":"Parallel protein detection by solid-phase proximity ligation assay with real-time PCR or sequencing","volume":"109","author":"Ebai","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.ebiom.2026.106348_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ebiom.2026.106348_bib34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ebiom.2026.106348_bib35","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1007\/s00415-020-09998-8","article-title":"Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"268","author":"Querol","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.ebiom.2026.106348_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117636119","article-title":"Myeloid caspase-8 restricts RIPK3-dependent proinflammatory IL-1 beta production and CD4 T cell activation in autoimmune demyelination","volume":"119","author":"Kim","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2026.106348_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jns.12608","article-title":"Prognostic value of neurofilament light in blood in patients with polyneuropathy: a systematic review","volume":"29","author":"Kodal","year":"2024","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ebiom.2026.106348_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","article-title":"Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology","volume":"31","author":"Ransohoff","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2026.106348_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.ebiom.2026.106348_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106348_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:19Z","timestamp":1783498459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S2352396426002318"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106348","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106348"}}